vs

Side-by-side financial comparison of CLARIVATE PLC (CLVT) and NU SKIN ENTERPRISES, INC. (NUS). Click either name above to swap in a different company.

CLARIVATE PLC is the larger business by last-quarter revenue ($585.5M vs $370.3M, roughly 1.6× NU SKIN ENTERPRISES, INC.). NU SKIN ENTERPRISES, INC. runs the higher net margin — 3.9% vs -6.9%, a 10.8% gap on every dollar of revenue. On growth, CLARIVATE PLC posted the faster year-over-year revenue change (-1.4% vs -16.9%). CLARIVATE PLC produced more free cash flow last quarter ($78.9M vs $5.9M). Over the past eight quarters, CLARIVATE PLC's revenue compounded faster (-5.1% CAGR vs -5.8%).

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

CLVT vs NUS — Head-to-Head

Bigger by revenue
CLVT
CLVT
1.6× larger
CLVT
$585.5M
$370.3M
NUS
Growing faster (revenue YoY)
CLVT
CLVT
+15.5% gap
CLVT
-1.4%
-16.9%
NUS
Higher net margin
NUS
NUS
10.8% more per $
NUS
3.9%
-6.9%
CLVT
More free cash flow
CLVT
CLVT
$73.0M more FCF
CLVT
$78.9M
$5.9M
NUS
Faster 2-yr revenue CAGR
CLVT
CLVT
Annualised
CLVT
-5.1%
-5.8%
NUS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLVT
CLVT
NUS
NUS
Revenue
$585.5M
$370.3M
Net Profit
$-40.2M
$14.5M
Gross Margin
67.2%
70.7%
Operating Margin
5.2%
6.3%
Net Margin
-6.9%
3.9%
Revenue YoY
-1.4%
-16.9%
Net Profit YoY
61.3%
140.1%
EPS (diluted)
$-0.06
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLVT
CLVT
NUS
NUS
Q1 26
$585.5M
Q4 25
$617.0M
$370.3M
Q3 25
$623.1M
$364.2M
Q2 25
$621.4M
$386.1M
Q1 25
$593.7M
$364.5M
Q4 24
$663.0M
$445.6M
Q3 24
$622.2M
$430.1M
Q2 24
$650.3M
$439.1M
Net Profit
CLVT
CLVT
NUS
NUS
Q1 26
$-40.2M
Q4 25
$3.1M
$14.5M
Q3 25
$-28.3M
$17.1M
Q2 25
$-72.0M
$21.1M
Q1 25
$-103.9M
$107.5M
Q4 24
$-191.8M
$-36.1M
Q3 24
$-65.6M
$8.3M
Q2 24
$-304.3M
$-118.3M
Gross Margin
CLVT
CLVT
NUS
NUS
Q1 26
67.2%
Q4 25
66.8%
70.7%
Q3 25
65.0%
70.5%
Q2 25
67.2%
68.8%
Q1 25
65.1%
67.8%
Q4 24
65.7%
62.7%
Q3 24
66.2%
70.1%
Q2 24
67.2%
70.0%
Operating Margin
CLVT
CLVT
NUS
NUS
Q1 26
5.2%
Q4 25
6.7%
6.3%
Q3 25
7.1%
5.9%
Q2 25
1.1%
8.0%
Q1 25
-3.5%
-2.7%
Q4 24
-9.4%
-11.9%
Q3 24
3.5%
4.2%
Q2 24
-36.9%
-28.6%
Net Margin
CLVT
CLVT
NUS
NUS
Q1 26
-6.9%
Q4 25
0.5%
3.9%
Q3 25
-4.5%
4.7%
Q2 25
-11.6%
5.5%
Q1 25
-17.5%
29.5%
Q4 24
-28.9%
-8.1%
Q3 24
-10.5%
1.9%
Q2 24
-46.8%
-26.9%
EPS (diluted)
CLVT
CLVT
NUS
NUS
Q1 26
$-0.06
Q4 25
$0.00
$0.27
Q3 25
$-0.04
$0.34
Q2 25
$-0.11
$0.43
Q1 25
$-0.15
$2.14
Q4 24
$-0.27
$-0.73
Q3 24
$-0.09
$0.17
Q2 24
$-0.46
$-2.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLVT
CLVT
NUS
NUS
Cash + ST InvestmentsLiquidity on hand
$239.8M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$4.8B
$805.2M
Total Assets
$10.9B
$1.4B
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLVT
CLVT
NUS
NUS
Q1 26
Q4 25
$329.2M
$239.8M
Q3 25
$318.7M
$253.0M
Q2 25
$362.6M
$265.4M
Q1 25
$354.0M
$213.6M
Q4 24
$295.2M
$198.0M
Q3 24
$388.5M
$237.8M
Q2 24
$376.4M
$232.9M
Total Debt
CLVT
CLVT
NUS
NUS
Q1 26
$4.3B
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.6B
Q2 24
$4.6B
Stockholders' Equity
CLVT
CLVT
NUS
NUS
Q1 26
$4.8B
Q4 25
$4.8B
$805.2M
Q3 25
$4.9B
$799.8M
Q2 25
$5.0B
$787.8M
Q1 25
$5.0B
$754.0M
Q4 24
$5.1B
$651.5M
Q3 24
$5.5B
$706.9M
Q2 24
$5.6B
$686.2M
Total Assets
CLVT
CLVT
NUS
NUS
Q1 26
$10.9B
Q4 25
$11.1B
$1.4B
Q3 25
$11.2B
$1.4B
Q2 25
$11.4B
$1.4B
Q1 25
$11.5B
$1.4B
Q4 24
$11.5B
$1.5B
Q3 24
$12.0B
$1.6B
Q2 24
$12.1B
$1.6B
Debt / Equity
CLVT
CLVT
NUS
NUS
Q1 26
0.89×
Q4 25
0.89×
Q3 25
0.90×
Q2 25
0.90×
Q1 25
0.90×
Q4 24
0.88×
Q3 24
0.84×
Q2 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLVT
CLVT
NUS
NUS
Operating Cash FlowLast quarter
$134.7M
$16.6M
Free Cash FlowOCF − Capex
$78.9M
$5.9M
FCF MarginFCF / Revenue
13.5%
1.6%
Capex IntensityCapex / Revenue
9.5%
2.9%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$333.9M
$46.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLVT
CLVT
NUS
NUS
Q1 26
$134.7M
Q4 25
$159.9M
$16.6M
Q3 25
$181.1M
$27.5M
Q2 25
$116.3M
$35.8M
Q1 25
$171.2M
$389.0K
Q4 24
$141.3M
$25.8M
Q3 24
$202.9M
$31.4M
Q2 24
$126.2M
$51.2M
Free Cash Flow
CLVT
CLVT
NUS
NUS
Q1 26
$78.9M
Q4 25
$89.2M
$5.9M
Q3 25
$115.5M
$17.6M
Q2 25
$50.3M
$35.8M
Q1 25
$110.3M
$-13.2M
Q4 24
$59.1M
$13.2M
Q3 24
$126.3M
$22.8M
Q2 24
$60.3M
$43.1M
FCF Margin
CLVT
CLVT
NUS
NUS
Q1 26
13.5%
Q4 25
14.5%
1.6%
Q3 25
18.5%
4.8%
Q2 25
8.1%
9.3%
Q1 25
18.6%
-3.6%
Q4 24
8.9%
3.0%
Q3 24
20.3%
5.3%
Q2 24
9.3%
9.8%
Capex Intensity
CLVT
CLVT
NUS
NUS
Q1 26
9.5%
Q4 25
11.5%
2.9%
Q3 25
10.5%
2.7%
Q2 25
10.6%
0.0%
Q1 25
10.3%
3.7%
Q4 24
12.4%
2.8%
Q3 24
12.3%
2.0%
Q2 24
10.1%
1.9%
Cash Conversion
CLVT
CLVT
NUS
NUS
Q1 26
Q4 25
51.58×
1.15×
Q3 25
1.61×
Q2 25
1.69×
Q1 25
0.00×
Q4 24
Q3 24
3.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLVT
CLVT

Subscription$397.5M68%
Re-occurring$108.6M19%
Transactional$79.4M14%

NUS
NUS

Other$161.9M44%
Mainland China Segment$52.0M14%
Southeast Asia Pacific Segment$50.5M14%
Europe And Africa Segment$41.8M11%
Hong Kong Taiwan Segment$29.6M8%
South Korea Segment$28.4M8%
Rhyz Other Segment$6.1M2%

Related Comparisons